Kabiven NDC 63323-712

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-712Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0712Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63323-712-10	63323071210	1026 mL in 1 BAG (63323-712-10)Marketed from Aug 25, 2014
63323-712-15	63323071215	1540 mL in 1 BAG (63323-712-15)Marketed from Aug 25, 2014
63323-712-20	63323071220	2053 mL in 1 BAG (63323-712-20)Marketed from Aug 25, 2014
63323-712-25	63323071225	2566 mL in 1 BAG (63323-712-25)Marketed from Aug 25, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Kabiven
Generic name (nonproprietary): dextrose, soybean oil, electrolytes, lysine, phenylalanine, leucine, valine, threonine, methionine, isoleucine, tryptophan, alanine, arginine, glycine, proline, histidine, glutamic acid, serine, aspartic acid and tyrosine
Active ingredients: Dextrose monohydrate — 10.8 g/100mLSoybean oil — 3.9 g/100mLSodium acetate — 239 mg/100mLPotassium chloride — 174 mg/100mLSodium glycerophosphate anhydrous — 147 mg/100mLMagnesium sulfate heptahydrate — 96 mg/100mLCalcium chloride — 29 mg/100mLLysine hydrochloride — 263 mg/100mLPhenylalanine — 231 mg/100mLLeucine — 231 mg/100mLValine — 213 mg/100mLHistidine — 199 mg/100mLThreonine — 164 mg/100mLMethionine — 164 mg/100mLIsoleucine — 164 mg/100mLTryptophan — 55 mg/100mLAlanine — 467 mg/100mLArginine — 330 mg/100mLGlycine — 231 mg/100mLProline — 199 mg/100mLGlutamic acid — 164 mg/100mLSerine — 131 mg/100mLAspartic acid — 99 mg/100mLTyrosine — 6.7 mg/100mL
Dosage form: Injection, Emulsion
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 200656
Marketing start: Aug 25, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Amino Acids (Chemical structure)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Lipids (Chemical structure)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 63323-712_f4e7d197-8c8f-4603-ae34-cd4c204d89c3SPL ID f4e7d197-8c8f-4603-ae34-cd4c204d89c3SPL set ID afeb4837-a759-4484-a76e-e04611c459e7UNII LX22YL083G, 241ATL177A, 4550K0SC9B, 660YQ98I10, YP1H63LJ2K, SK47B8698T, M4I0D6VV5M, JNJ23Q2COM, 47E5O17Y3R, GMW67QNF9C, HG18B9YRS7, 4QD397987E, 2ZD004190S, AE28F7PNPL, 04Y7590D77, 8DUH1N11BX, OF5P57N2ZX, 94ZLA3W45F, TE7660XO1C, 9DLQ4CIU6V, 3KX376GY7L, 452VLY9402, 30KYC7MIAI, 42HK56048UUPC 0363323712105, 0363323712204, 0363323712150, 0363323712259
Pharmacologic class: Amino Acid; Blood Coagulation Factor; Calculi Dissolution Agent; Lipid Emulsion; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323071210 followed by a unit qualifier and the quantity

Package 63323-0712-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 11, 2025.

Indications (excerpt from the label)

KABIVEN is indicated as a source of calories, protein, electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. KABIVEN may be used to prevent essential fatty acid deficiency or treat negative nitrogen balance in adult patients. Limitations of Use: KABIVEN is not recommended for use in pediatric patients under the age of 2 years, including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group [see Warnings and Precautions ( 5.1 ) and Use in Specific Populations ( 8.4 )] . KABIVEN is indicated as a source of calor…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 200656

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 200656
Product	Strength	Form · route	Labeler	Product NDC
Perikabivendextrose, soybean oil, electrolytes, lysine, phenylalanine, leucine, valine, threonine, methionine, isoleucine, tryptophan, alanine, arginine, glycine, proline, histidine, glutamic acid, serine, aspartic acid and tyrosine	Dextrose monohydrate 7.5 g/100mL + 23 more ingredients	Injection, EmulsionIntravenous	Fresenius Kabi USA, LLC	63323-714